@article{bc948808b8524c108e30d3e09abeac62,
title = "Current research and treatment for epithelial ovarian cancer: A Position Paper from the Helene Harris Memorial Trust",
abstract = "In March 2003, an international mulltidisciplinary group of scientists and clinicians with a specific interest in ovarian cancer met for 4 days to discuss research into and treatment of this challenging disease. Under the headings of molecular genetics, molecular biology, the biology of ovarian cancer, old therapies, new targets and the early detection of the disease, this Position Paper summarises the presentations and discussion from the 9th Biennial Helene Harris Memorial Trust Forum on Ovarian Cancer. In particular, we highlight the potential of international collaborations in translating laboratory science into useful clinical interventions.",
keywords = "Early detection, International collaboration, New targets, Oeromic profiling, Ovarian cancer, Transcriptional profiling",
author = "F. Balkwill and Bast, {R. C.} and J. Berek and G. Chenevix-Trench and M. Gore and T. Hamilton and I. Jacobs and G. Mills and R. Souhami and N. Urban and S. Ursulic and J. Smyth",
note = "Funding Information: To identify the best set of markers for inclusion in a panel, it is necessary to evaluate several markers in combination in the same set of sera. Samples must be collected, processed and stored identically, because comparability between cases and controls is imperative. Validation studies of this kind are being conducted by at least two groups in the United States (US), both funded by the National Institutes of Health (NIH): the Early Detection Research Network (EDRN) and the Seattle Ovarian Specialized Program of Research Excellence (SPORE). Ultimately, a single prospective study that includes all of the best markers must be conducted, perhaps by investigators brought together by HHMT? ",
year = "2003",
month = sep,
doi = "10.1016/S0959-8049(03)00511-2",
language = "English (US)",
volume = "39",
pages = "1818--1827",
journal = "European Journal of Cancer",
issn = "0959-8049",
publisher = "Elsevier Limited",
number = "13",
}